Care Rail

← Medical · All 20 for Interstitial lung disease

Switzerland

Interstitial lung disease · Respiratory

High spend, high access, canton variation. Respiratory pathway via Mandatory private insurance.

Rank in this country#33
Share of deaths0.8%
Master rank#34
System quality rank#11

Access & coverage

Mandatory private insurance

Mandatory private insurance; high premiums; broad benefit baskets

Treatment

  • Inhaled bronchodilators / steroids per phenotype
  • Oxygen / NIV for advanced disease
  • Exacerbation pathways and hospital-at-home where available

Prevention

  • Tobacco control; clean air / occupational dust rules
  • Vaccination (flu, pneumococcal, COVID) for high-risk groups
  • Early COPD case-finding in smokers

Lifestyle

  • Smoking cessation is the dominant lever
  • Pulmonary rehab exercise + breathing training
  • Avoid indoor smoke and occupational triggers

What stands out here

Same broad respiratory toolkit as peers — differences are coverage rules, wait times, prices, and follow-through.

vs master: +0.0 percentage points vs Top 20 average share.